Latest news
25 items- PRBIOLASE Showcases Advanced YSGG Laser Solutions for Periodontal and Implant Care at GNYDM 2025NEW YORK, Nov. 25, 2025 /PRNewswire/ -- BIOLASE, the global leader in dental lasers, announced its participation in the 2025 Greater New York Dental Meeting (GNYDM), taking place November 28–December 3 in New York City. As part of the program, BIOLASE will host a featured lecture led by Philip Kang, DDS, focused on advancing laser solutions for periodontal and implant health. BIOLASE to Highlight YSGG Laser Innovations at GNYDM 2025 Dr. Kang will present "Advancing Laser Solutions for Periodontal and Implant Health" on Sunday, November 30 from 10:00 AM to 12:30 PM on the GNYDM
- SECSEC Form 8-K filed by Biolase Inc.8-K - BIOLASE, INC (0000811240) (Filer)
- PRBIOLASE Voluntarily Initiates Chapter 11 ProceedingsLAKE FOREST, CA / ACCESSWIRE / October 1, 2024 / BIOLASE, Inc. (NASDAQ:BIOL) (the "Company"), a global leader in dental lasers, today announced that the Company and its direct domestic subsidiaries have voluntarily initiated Chapter 11 proceedings (the "Bankruptcy Petitions") in the United States Bankruptcy Court for the District of Delaware (the "Court"). BIOLASE will seek Court approval to continue operating during the proceedings and remains focused on providing its customers with its award-winning dental lasers and customer service.The Company also announced today that it is pursuing a sale process under Section 363 of the Bankruptcy Code in conjunction with the filing. To this end, BIOL
- SECBiolase Inc. filed SEC Form 8-K: Bankruptcy or Receivership8-K - BIOLASE, INC (0000811240) (Filer)
- SECSEC Form 8-K filed by Biolase Inc.8-K - BIOLASE, INC (0000811240) (Filer)
- SECSEC Form 8-K filed by Biolase Inc.8-K - BIOLASE, INC (0000811240) (Filer)
- SECSEC Form 10-Q filed by Biolase Inc.10-Q - BIOLASE, INC (0000811240) (Filer)
- PRBIOLASE Reports 2024 Second Quarter Results; Achieves 40% Gross Margin as Global Consumable Sales StrengthenLAKE FOREST, CA / ACCESSWIRE / August 8, 2024 / BIOLASE, Inc. (NASDAQ:BIOL), a leader in dental laser technology, today reported its financial results for the second quarter ended June 30, 2024."We experienced another strong quarter in consumable revenue, recording our second-highest mark ever and achieving over 600 recurring subscriptions," commented John Beaver, President and Chief Executive Officer of BIOLASE. "This success translates to over $2 million in scheduled shipments over the next twelve months. Our gross margin increased to 40%, up from 33% in the first quarter of 2024, due to cost reduction efforts implemented earlier in the year. Despite ongoing revenue challenges due to highe
- SECBiolase Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - BIOLASE, INC (0000811240) (Filer)
- SECBiolase Inc. filed SEC Form 8-K: Unregistered Sales of Equity Securities, Financial Statements and Exhibits8-K - BIOLASE, INC (0000811240) (Filer)
- PRSWK Holdings Highlights Recent Achievements and Provides Portfolio UpdateDALLAS, TX / ACCESSWIRE / July 17, 2024 / SWK Holdings Corporation (NASDAQ:SWKH) ("SWK" or the "Company"), a life science-focused specialty finance company catering to small and mid-sized commercial-stage companies, today provided a corporate progress update as well as a summary of the achievements of its borrower portfolio companies."During the second quarter we advanced capital to two existing borrowers and are working towards an additional closing in the next month," said SWK President and CEO Jody Staggs."Importantly, several of our borrower partners took advantage of the strong capital markets to raise equity or other forms of non-dilutive financing. We also repurchased $1 million of st
- NEWS12 Health Care Stocks Moving In Wednesday's After-Market SessionGainers Nexalin Technology (NASDAQ:NXL) stock increased by 48.1% to $1.54 during Wednesday's after-market session. The company's market cap stands at $11.4 million. Tempest Therapeutics (NASDAQ:TPST) stock moved upwards by 40.0% to $3.99. The market value of their outstanding shares is at $88.6 million. ASLAN Pharma (NASDAQ:ASLN) stock increased by 18.51% to $0.37. The market value of their outstanding shares is at $8.3 million. Talphera (NASDAQ:TLPH) shares increased by 15.18% to $0.9. The company's market cap stands at $15.2 million. Geovax Labs (NASDAQ:GOVX) stock rose 13.15% to $2.15. The market value of their outstanding shares is at $5.4 million. SAB Biotherapeutics (NASDAQ:SABS)
- NEWS12 Health Care Stocks Moving In Wednesday's Pre-Market SessionGainers Sonoma Pharmaceuticals (NASDAQ:SNOA) shares rose 60.2% to $0.27 during Wednesday's pre-market session. The market value of their outstanding shares is at $4.2 million. As per the press release, Q4 earnings came out 2 days ago. Mustang Bio (NASDAQ:MBIO) stock moved upwards by 31.21% to $0.98. The market value of their outstanding shares is at $27.7 million. Geovax Labs (NASDAQ:GOVX) shares increased by 24.32% to $1.38. The market value of their outstanding shares is at $3.4 million. Silk Road Medical (NASDAQ:SILK) stock increased by 23.67% to $26.8. The company's market cap stands at $1.0 billion. Onconetix (NASDAQ:ONCO) shares rose 18.91% to $0.19. The market value of their outs
- NEWSBiolase shares are trading lower after the company announced that it will delist from the Nasdaq.
- NEWS12 Health Care Stocks Moving In Tuesday's After-Market SessionGainers Nexalin Technology (NASDAQ:NXL) shares rose 55.8% to $1.62 during Tuesday's after-market session. The market value of their outstanding shares is at $12.0 million. Dynatronics (NASDAQ:DYNT) stock rose 14.74% to $0.4. The company's market cap stands at $2.1 million. Oncology Institute (NASDAQ:TOI) shares moved upwards by 10.8% to $0.45. The market value of their outstanding shares is at $33.5 million. SAB Biotherapeutics (NASDAQ:SABS) stock rose 8.94% to $2.8. The market value of their outstanding shares is at $25.8 million. Bone Biologics (NASDAQ:BBLG) shares moved upwards by 8.04% to $1.61. The company's market cap stands at $1.7 million. Virpax Pharmaceuticals (NASDAQ:VRPX) s
- NEWSBIOLASE To Delist from Nasdaq
- PRBIOLASE Announces Delisting from NasdaqLAKE FOREST, CA / ACCESSWIRE / June 18, 2024 / BIOLASE, Inc. (NASDAQ:BIOL), a global leader in dental lasers, today announced that the Company received a notice from Nasdaq that it has determined to delist the shares of the Company's common stock from The Nasdaq Stock Market. The delisting is a result of failure to satisfy the $1.00 minimum bid price listing requirement in Nasdaq Listing Rule 5550(a)(2) and failure to comply with Nasdaq's $2,500,000 minimum stockholders' equity requirement for continued listing or any of the alternative requirements in Listing Rule 5550(b). Suspension of trading in the Company's common stock on the Nasdaq exchange will be effective at the open of trading on
- NEWS12 Health Care Stocks Moving In Tuesday's Pre-Market SessionGainers Sonoma Pharmaceuticals (NASDAQ:SNOA) stock increased by 63.8% to $0.28 during Tuesday's pre-market session. The company's market cap stands at $4.3 million. As per the news, the Q4 earnings report came out yesterday. Qualigen Therapeutics (NASDAQ:QLGN) stock rose 31.57% to $0.23. The company's market cap stands at $1.4 million. Mustang Bio (NASDAQ:MBIO) shares rose 30.66% to $0.98. The company's market cap stands at $27.6 million. Autonomix Medical (NASDAQ:AMIX) stock rose 25.92% to $1.7. The market value of their outstanding shares is at $32.0 million. Silk Road Medical (NASDAQ:SILK) shares moved upwards by 23.9% to $26.85. The market value of their outstanding shares is at $1.
- SECBiolase Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits8-K - BIOLASE, INC (0000811240) (Filer)
- SECSEC Form S-1 filed by Biolase Inc.S-1 - BIOLASE, INC (0000811240) (Filer)
- SECSEC Form 8-K filed by Biolase Inc.8-K - BIOLASE, INC (0000811240) (Filer)
- NEWSWhy Alibaba Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionShares of Alibaba Group Holding Limited (NYSE:BABA) fell sharply during Tuesday's session following mixed first-quarter financial results. The e-commerce giant reported fiscal fourth-quarter 2023 revenue growth of 7% year-on-year to $30.73 billion, beating the analyst consensus estimate of $30.40 billion. Adjusted earnings per ADS of $1.40 missed the analyst consensus estimate of $1.41, according to data from Benzinga Pro. Alibaba Group shares tumbled 6.8% to $78.86 on Tuesday. Here are some other stocks moving in today’s mid-day session. Gainers Cheetah Net Supply Chain Service Inc. (NASDAQ:CTNT) shares jumped 352.4% to $5.34 as the company reported pricing of $8.19 million
- NEWS12 Health Care Stocks Moving In Tuesday's Intraday SessionGainers Delcath Systems (NASDAQ:DCTH) stock rose 33.2% to $7.19 during Tuesday's regular session. The company's market cap stands at $199.8 million. As per the news, the Q1 earnings report came out today. Harrow (NASDAQ:HROW) stock rose 32.64% to $16.01. The company's market cap stands at $566.4 million. As per the press release, Q1 earnings came out yesterday. ProKidney (NASDAQ:PROK) shares moved upwards by 26.29% to $3.89. The company's market cap stands at $248.6 million. As per the news, the Q1 earnings report came out 2 days ago. Sunshine Biopharma (NASDAQ:SBFM) stock rose 25.14% to $1.09. The market value of their outstanding shares is at $1.0 million. Pacific Biosciences (NASDAQ:
- NEWSBenchmark Reiterates Speculative Buy on Biolase, Maintains $0.4 Price TargetBenchmark analyst Bruce Jackson reiterates Biolase (NASDAQ:BIOL) with a Speculative Buy and maintains $0.4 price target.
- NEWSWhy Alcon Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving PremarketShares of Alcon Inc. (NYSE:ALC) rose sharply in today's pre-market trading following better-than-expected first-quarter earnings. Alcon posted adjusted earnings of 78 cents per share, beating market expectations of 63 cents per share. The company's quarterly sales came in at $2.444 billion versus estimates of $2.462 billion, according to data from Benzinga Pro. Alcon shares jumped 10.8% to $89.40 in the pre-market trading session. Here are some other stocks moving in pre-market trading. Gainers GameStop Corp. (NYSE:GME) gained 40.2% to $42.70 in pre-market trading after jumping over 74% on Monday. Faraday Future Intelligent Electric Inc. (NASDAQ:FFIE) gained 39.2% to $0.08
BIOL FAQ
5 questionsWhat does Biolase Inc. do?
BIOLASE, Inc., together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, such as cosmetic, restorative, and complex surgical applications. The company offers Waterlase all-tissue dental laser systems for cutting soft and hard tissues; diode laser systems for soft tissue, pain therapy, teeth whitening, and...Where does BIOL stock trade?
Biolase Inc. (BIOL) is listed on NASDAQ.What sector and industry is BIOL in?
Biolase Inc. operates in the Health Care sector, Medical/Dental Instruments industry.What companies are similar to BIOL?
Notable peers in the same industry include SYK (Stryker Corporation), MMM (3M Company), BSX (Boston Scientific Corporation), MDLN (Medline Inc.), BDX (Becton Dickinson and Company). Compare BIOL side-by-side with any of them on Quantisnow.How can I track BIOL on Quantisnow?
Quantisnow aggregates Biolase Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow BIOL to receive live email and push alerts on every new disclosure.